HHTM

CHICAGO, ILLINOIS – The Beltone Hearing Care Foundation, a registered 501(c)(3) charity founded by Beltone, has announced its ‘Hear for the Holidays’ hearing aid giveaway to commemorate a decade of providing hearing solutions to those in need. From November 1 to December 31, 2024, nominations are being accepted for individuals who would benefit from receiving a new set of Beltone

AURORA, ILLIONOIS – Unitron has announced the official launch of two new Vivante™ styles, Stride™ V-M and Stride V-SP, expanding the company’s range of hearing solutions on the Vivante platform and providing patients with more options to meet their needs. Designed for flexibility and comfort, Stride V-M and Stride V-SP increase the variety of choices available within Unitron’s portfolio. Both

EDEN PRAIRIE, MINNESOTA – Starkey, the only American-owned major hearing aid manufacturer, last week announced that its newest hearing technology, Edge AI, is now available through the Veterans Affairs Administration, Department of Defense and the Indian Health Service. Building on the success of Genesis AI, “Edge AI represents the next leap in intelligent hearing technology, redefining the patient and provider

ELEHEAR is positioning itself as a forward-thinking player in the OTC hearing aid market, evolving from an OEM supplier to a direct-to-consumer brand focused on accessibility and innovation. Shari Eberts talks with Jalene Nadeau, Chief Audiologist & Director of Customer Support at ELEHEAR, about the company’s strategic shift and their efforts to make high-quality hearing technology widely available. Jalene explains

VIENNA, AUSTRIA — A recent study led by a research team at MedUni Vienna highlights the potential of AC102, a new active substance that could mark a significant advancement in the treatment of acute hearing disorders, including sudden hearing loss. The promising findings, published in Cell Death & Disease, stem from preclinical trials and offer a glimpse of hope for

Click here to read the November 2024 NeuroAudiology Newsletter.

BALLERUP, DENMARK – GN today announced the release its Interim Report for Q3 2024. The company experienced further margin expansion and strong cash flow, despite facing varying growth trends across its divisions. Financial Highlights and Strategic Initiatives Hearing Division: Achieved 10% organic revenue growth, fueled by market share gains and the continued success of the ReSound Nexia product line. The

Western Australian innovators have developed ClearDrum, the world’s first prosthetic device designed to repair chronic ruptured eardrums, a significant advancement with global implications for ear health. Lead researcher Dr. Filippo Valente has secured $143,316 (AUD) in funding from the state government to prepare for manufacturing and clinical trials of this groundbreaking technology. ClearDrum is an implantable prosthetic eardrum made using

How can AI make the journey to better hearing smoother for OTC hearing aid users? In this episode from the EUHA show floor, Tuned co-founders Omri Gavish and Ron Ganot, joined by Board Advisor Delain Wright, discuss their recent collaboration with JVC to introduce hearing aids equipped with streaming and rechargeability. More importantly, they reveal Tuned’s AI-based care model, which

WHITE BEAR LAKE, MINNESOTA — Envoy Medical®, Inc. (NASDAQ: “COCH”), a hearing health company specializing in fully implanted hearing systems, announced the U.S. Food and Drug Administration’s (FDA) approval of its Investigational Device Exemption (IDE) application for a pivotal study of the Acclaim® Fully Implanted Cochlear Implant. The Acclaim® technology includes an implanted sensor that leverages the ear’s natural anatomy